project id: TCGA-OV; case submitter id: TCGA-25-1322; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 9.5; spectrophotometer method: UV Spec; age at index: 62; days to birth: -22646; days to death: 91; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1939; year of death: 2001; age at diagnosis: 22646; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 91.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2001; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.8; longest dimension: 2.6; oct embedded: No; shortest dimension: 0.8; portion submitter id: TCGA-25-1322-01A-01; percent necrosis: 15.0; percent stromal cells: 10.0; percent tumor cells: 75.0; percent tumor nuclei: 95.0;